Vikas Sinha Insider Trading
Get free email notifications about insider trading for Vikas Sinha.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vikas Sinha. Vikas Sinha is a CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a Sr VP and CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a Sr. VP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a SVP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a SVP & Chief Financial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a SVP, CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in Verona Pharma plc ($VRNA) and a See Remarks in Allovir, Inc. ($ALVR).
Address: C/O ALEXION PHARMACUETICALS, INC. 352 KNOTTER DRIVE CHESHIRE 06410 CT
Companies in which Vikas Sinha is an Insider
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vikas Sinha: EVP & CFO, SVP, CFO, Sr. VP & CFO, Sr VP and CFO, SVP & CFO, SVP & Chief Financial Officer
Holdings: 178,463 shares
Current Value: $22,793,294
Latest Transaction: Aug 10 2016
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Allovir, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Vikas Sinha: See Remarks
Holdings: 865,407 shares
Latest Transaction: Jan 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verona Pharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vikas Sinha: Director
Holdings: 74,440 shares
Latest Transaction: May 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Vikas Sinha
Sentiment: All, ALXN, ALVR, VRNA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.84 | 10,016 | 8,410 | 74,440 | 84.5 K to 74.4 K (-11.86 %) |
| Feb 03 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.99 | 10,224 | 10,161 | 84,456 | 94.7 K to 84.5 K (-10.80 %) |
| Jan 21 2021 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks | Option Exercise | A | 42.15 | 109,200 | 4,602,780 | 109,200 | |
| Jan 21 2021 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks | Grant | A | 0.00 | 58,800 | 0 | 865,407 | 806.6 K to 865.4 K (+7.29 %) |
| Aug 05 2020 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks | Buy | C | 0.00 | 13,420,970 | 0 | 13,420,970 | 0 to 13.4 M |
| Jul 31 2020 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks | Option Exercise | A | 17.00 | 436,900 | 7,427,300 | 436,900 |